• eHealth outlined a three-year plan that frames 2026 as a bridge year, with revenue expected to return to growth in 2027 at a mid-single-digit rate year over year, accelerating to mid-teens growth in 2028.
• Profitability targets call for adjusted EBITDA margin to reach 20% by 2028, with positive operating cash flow in 2027 and positive operating and free cash flow in 2028.
• The presentation highlighted $1 billion of commissions receivable as of 3/31/2026, compared with enterprise value of $454 million.
• Balance sheet figures as of 3/31/2026 showed cash, equivalents, and short-term marketable securities of $110.8 million, long-term debt of $113.8 million, and convertible preferred stock of $393.9 million carrying an 8% annual dividend.
• Strategy updates included expanded AI use in enrollment workflows, citing a 240 bps end-to-end conversion lift for an AI screener versus a human screener, alongside a “Lifetime Advisory” model aimed at improving persistency and increasing ancillary product sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. eHealth Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.